Furthermore, the knockdown of ATOX1, but not CCS, significantly increased the sensitivity of pancreatic adenocarcinoma cells to the genotoxic drugs gemcitabine and adriamycin [45]. This evidence concerns the gene ATOX1 and pancreatic adenocarcinoma.